Hyperesthesia one year after breast augmentation surgery increases the odds for persisting pain at four years A prospective four-year follow-up study
Authors:
- 1 April 2010
- journal article
- research article
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Pain
- Vol. 1 (2) , 75-81
Abstract
In this long-term follow-up study of 175 women, we investigated the prevalence of and factors associated with persisting pain and sensory changes four years after augmentation mammoplasty. Previously the women had participated in an acute postoperative pain study, and follow-up investigations at 6 weeks and 1 year after surgery. In the present study, the women were mailed questionnaires about pain, sensory changes, and affection of daily life, quality of life and pain catastrophizing 4 years after surgery. One hundred and sixteen women answered the questionnaire. The fraction of women reporting evoked- and/or spontaneous pain during the last 24 h had declined from 20% at 1 year to 14% at 4 years. Hyperesthesia had declined from 46% at 1 year to 32% at 4 years, while the change in hypoesthesia was small, 47% at 1 year to 51% at 4 years. Methylprednisolone and parecoxib given pre incisionally reduced acute postoperative pain and reduced the prevalence of hyperesthesia after 6 weeks/1 year, but after 4 years we found no significant differences between the test drug groups. Those having concomitant pain and hyperesthesia at 6 weeks and 1 year had high odds for persisting pain at 4 years (OR 7.8, 95% CI 2.1–29.8, P = 0.003; OR 13.2, 95% CI 2.5–71.3, P = 0.003). In patients without pain but with hyperesthesia at 1 year, the hyperesthesia increased the odds for pain at 4 years (OR 2.6 95% CI 1.1–6.1, P = 0.03). Hypoesthesia at 6 weeks or at 1 year did not affect the odds for pain at 4 years. A good general health condition (mental and physical) was associated with reduced odds for pain at 4 years (OR = 0.56, 95% CI 0.35–0.88, P = 0.01). However, using the Short Form health survey, SF-12, the Mental Component Summary Score seemed to affect the odds for chronic pain more than the Physical Component Summary Score. To conclude, the prevalence of pain and hyperesthesia after breast augmentation declined from 1 to 4 years. Nevertheless, the most striking finding in the current trial was that pain coinciding with hyperesthesia at 6 weeks and 1 year resulted in highly increased odds for persistent postoperative pain. Even hyperesthesia alone, without pain, increased the odds for chronic postsurgical pain. Thus, the present study suggests hyperesthesia as an independent risk factor for chronic postsurgical pain.Keywords
This publication has 30 references indexed in Scilit:
- Persistent pain after groin hernia surgery: a qualitative analysis of pain and its consequences for quality of lifeActa Anaesthesiologica Scandinavica, 2009
- Long-Term Cosmetic Outcome After Breast ImplantationAnnals of Plastic Surgery, 2007
- Chronic pain and sensory changes after augmentation mammoplasty: Long term effects of preincisional administration of methylprednisolonePain, 2006
- The measurement of postoperative pain: A comparison of intensity scales in younger and older surgical patientsPain, 2005
- Neuronal Plasticity: Increasing the Gain in PainScience, 2000
- Short Form 36 (SF-36) health survey: normative data from the general Norwegian populationScandinavian Journal of Public Health, 1998
- Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine CountriesJournal of Clinical Epidemiology, 1998
- Acute Pain after Thoracic Surgery Predicts Long-Term Post-Thoracotomy PainThe Clinical Journal of Pain, 1996
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- The Pain Catastrophizing Scale: Development and validation.Psychological Assessment, 1995